Copyright: ©Author(s) 2026.
World J Stem Cells. Sep 26, 2026; 18(9): 124515
Published online Sep 26, 2026. doi: 10.4252/wjsc.124515
Published online Sep 26, 2026. doi: 10.4252/wjsc.124515
Table 4 Subgroup analysis
| Subgroup | Number of studies included | Test for heterogeneity | Effect model | SMD/WMD (95%CI) | P value | |
| I2 (%) | P value | |||||
| Lung histopathology score | ||||||
| Stem cell type | ||||||
| BMSCs | 13 | 86 | < 0.001 | Random | -2.95 (-3.96 to -1.93) | < 0.001 |
| Non-BMSCs | 6 | 89 | < 0.001 | Random | -2.87 (-4.46 to -1.29) | < 0.001 |
| Transplantation route | ||||||
| Tail vein | 17 | 83 | < 0.001 | Random | -2.37 (-3.12 to -1.62) | < 0.001 |
| Femoral vein | 2 | 79 | 0.03 | Random | -8.09 (-12.90 to -3.28) | 0.001 |
| Transplantation duration | ||||||
| < 6 hours | 12 | 89 | < 0.001 | Random | -3.34 (-4.50 to -2.18) | < 0.001 |
| ≥ 6 hours | 7 | 79 | < 0.001 | Random | -2.15 (-3.29 to -1.00) | < 0.001 |
| Follow-up duration | ||||||
| < 24 hours | 10 | 88 | < 0.001 | Random | -3.21 (-4.46 to -1.95) | < 0.001 |
| ≥ 24 hours | 9 | 86 | < 0.001 | Random | -2.62 (-3.79 to -1.46) | < 0.001 |
| Lung MPO activity | ||||||
| Stem cell type | ||||||
| BMSCs | 10 | 79 | < 0.001 | Random | -3.03 (-4.22 to -1.85) | < 0.001 |
| Non-BMSCs | 2 | 39 | 0.2 | Random | -2.56 (-4.15 to -0.97) | 0.002 |
| Transplantation route | ||||||
| Tail vein | 8 | 78 | < 0.001 | Random | -4.39 (-6.35 to -2.43) | < 0.001 |
| Femoral vein | 4 | 69 | 0.02 | Random | -2.00 (-2.93 to -1.07) | < 0.001 |
| Transplantation duration | ||||||
| < 6 hours | 5 | 87 | < 0.001 | Random | -7.32 (-12.13 to -2.51) | 0.003 |
| ≥ 6 hours | 7 | 58 | 0.03 | Random | -2.24 (-2.98 to -1.50) | < 0.001 |
| Follow-up duration | ||||||
| < 24 hours | 6 | 81 | < 0.001 | Random | -3.07 (-4.91 to -1.22) | 0.001 |
| ≥ 24 hours | 6 | 79 | < 0.001 | Random | -4.47 (-6.82 to -2.12) | < 0.001 |
| Lung wet/dry weight ratio | ||||||
| Stem cell type | ||||||
| BMSCs | 16 | 89 | < 0.001 | Random | -0.46 (-0.61 to -0.32) | < 0.001 |
| Non-BMSCs | 2 | 0 | 0.33 | Random | -0.87 (-1.13 to -0.61) | < 0.001 |
| Transplantation route | ||||||
| Tail vein | 16 | 88 | < 0.001 | Random | -0.50 (-0.66 to -0.34) | < 0.001 |
| Femoral vein | 2 | 95 | < 0.001 | Random | -0.54 (-1.02 to -0.06) | 0.03 |
| Transplantation duration | ||||||
| < 6 hours | 16 | 89 | < 0.001 | Random | -0.46 (-0.61 to -0.32) | < 0.001 |
| ≥ 6 hours | 2 | 0 | 0.33 | Random | -0.87 (-1.13 to -0.61) | < 0.001 |
| Follow-up duration | ||||||
| < 24 hours | 14 | 84 | < 0.001 | Random | -0.46 (-0.59 to -0.33) | < 0.001 |
| ≥ 24 hours | 4 | 94 | < 0.001 | Random | -0.62 (-1.11 to -0.13) | 0.01 |
- Citation: Jing GX, Wang ZP, Sun HY, Zhang Y, Gu GQ. Mesenchymal stem cell transplantation for severe acute pancreatitis-associated lung injury: A meta-analysis of animal studies. World J Stem Cells 2026; 18(9): 124515
- URL: https://www.wjgnet.com/1948-0210/full/v18/i9/124515.htm
- DOI: https://dx.doi.org/10.4252/wjsc.124515